SYNCOM

Syncom Healthcare Limited has informed the Exchange about Delisting of its Equity Shares in accordance with Resolution Plan approved by the Mumbai bench of Hon'ble National Company Law Tribunal ("NCLT") vide its order dated June 14, 2021

Syncom Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2021.

This is to inform you that the Resolution Professional and Board of Directors of the Company at their Meeting held today 1.e., 14th August, 2021 inter-alia has considered and approved the Statement of Un-Audited Financial Results of the Company for the Quarter ended 30th June, 2021 along with the Limited Review Report given by the Statutory Auditors of the Company, as per Regulation 33 of the SEBI Listing Regulations and in compliance with the Indian Accounting Standards as per the provisions of the Companies (Indian Accounting Standards) Rules, 2015 ("the Rules") and other applicable laws.��T

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.

The Exchange has sought clarification from Syncom Healthcare Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended March 31, 2021

Syncom Healthcare Limited has informed the Exchange about related Party Transactions��on a consolidated basis, in the format specified in applicable accounting standards for the half year ended March 31, 2021

Approval of Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on Jun 30, 2021.

Syncom Healthcare Limited has informed the Exchange about approval of resolution plan by NCLT

Members of the Exchange are hereby informed that trading in equity shares of Syncom Healthcare Limited (ISIN: INE602K01014) shall be suspended w.e.f. June 29, 2021 pursuant to order dated June 14, 2021 passed by National Company Law Tribunal.

Syncom Healthcare Limited has informed the Exchange about Corporate Insolvency Resolution Process Approval of Resolution Plan by the NCLT, Mumbai Bench.

Syncom Healthcare Limited has informed the Exchange about Corporate Insolvency Resolution Process

Syncom Healthcare Limited has informed the Exchange regarding Resignation of Ms Farida Bhatia as Company Secretary & Compliance Officer of the company w.e.f. March 23, 2021.

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on February 14, 2021.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Syncom Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on December 30, 2020. Further, the company has informed the Exchange regarding voting results.

Syncom Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on December 30, 2020

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on December 30, 2020

Syncom Healthcare Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Dec-2020 to 30-Dec-2020 for the purpose of Annual General Meeting.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on December 07, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on December 07, 2020.

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

Syncom Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

Syncom Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

The Exchange had sought clarification from Syncom Healthcare Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed.

The Exchange has sought clarification from Syncom Healthcare Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on September 15, 2020.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

Syncom Healthcare Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2020. '.

Syncom Healthcare Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2020. '.

Syncom Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Syncom Healthcare Limited has informed the Exchange regarding��Declaration Under Regulation 29(2) of SEBI SAST Regulations, 2011.

The Exchange has sought clarification from Syncom Healthcare Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 7(2) read with Regulations 6(2) of Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015'.

Syncom Healthcare Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 7(2) read with Regulations 6(2) of Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 '.

Syncom Healthcare Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 7(2) read with Regulations 6(2) of Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015'.

Syncom Healthcare Limited has informed the Exchange regarding 'Change in Shareholding-Prior Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015'.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on Jun 23, 2020.

Syncom Healthcare Limited has informed the Exchange about replacement of existing Interim Resolution Professional to Mr. Mangesh Kekre as Resolution Professional.

This is to inform you that statutory period of CIRP i.e. 180 days had expired on 10.02.2020 and an application for extension of CIRP for further period of 90 days was filed on behalf of under signed Resolution Professional (RP), to the Hon'ble National Company Law Tribunal Mumbai Bench. The Hon'ble National Company Law Tribunal Mumbai Bench has extended the CIRP period for further period of 90 days on 14th February, 2020. The copy of physical order is attached herewith for your reference.